1. HBW Insight
  2. >>Health
  4. >>Regulation

German Industry ‘Disappointed’ At Sildenafil’s Third Rx-To-OTC Switch Rejection

 
• By David Ridley

“The SVA has missed an opportunity to make an important contribution to patient safety and to strengthening personal responsibility,” commented Pharma Deutschland deputy general manager Elmar Kroth.

A man shows a thumb down. Gesture of disapproval and rejection. Bad assessment, harsh criticism, failure and defeat. Refusal to pass and cooperation. Bureaucratic obstacles. Contempt and condemnation
German switch committee rejects sildenafil switch for third time

Industry association Pharma Deutschland has expressed disappointment at the German switch committee’s (SVA’s) recent rejection of the Rx-to-OTC switch of sildenafil.

At its meeting on 21 January, the SVA voted 7-1 against the application to exempt erectile dysfunction treatment sildenafil 25mg and 50mg from Germany’s prescription requirement, making it the third...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Regulation

More from Geography